国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (4): 304-308.doi: 10. 3760/cma.j.cn115500-20241214-25411

• 综述 • 上一篇    下一篇

Dickkopf-1在糖尿病视网膜病变发生发展中的作用

李远葳1,2 黄雄高1,2   

  1. 1 海南医科大学第一附属医院眼科,海口 570101;2 海南医科大学第一附属医院急诊与创伤外科,急救与创伤研究教育部重点实验室,海南省创伤与灾难救援研究重点实验室,海口 571199
  • 收稿日期:2024-12-14 出版日期:2025-08-22 发布日期:2025-08-12
  • 通讯作者: 黄雄高,Email:hxg_eye@163.com E-mail:hxg_eye@163.com

Role of Dickkopf-1 in occurrence and development of diabetic retinopathy

Li Yuanwei1,2, Huang Xionggao1,2   

  1. 1 Department of Ophthalmology, the First Affiliated Hospital of Hainan Medical University, Haikou 570101, China; 2 Department of Emergency Surgery, the First Affiliated Hospital of Hainan Medical University; Key Laboratory of Emergency and Trauma of Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, Haikou 571199, China
  • Received:2024-12-14 Online:2025-08-22 Published:2025-08-12
  • Contact: Huang Xionggao, Email: hxg_eye@163.com E-mail:hxg_eye@163.com

摘要: Dickkopf(DKK)蛋白家族在生物发育和细胞信号转导中起至关重要的作用,其主要是通过对Wnt/β-catenin信号通路的调节影响细胞增生、凋亡和迁移,在许多疾病中发挥作用。DKK-1通过抑制Wnt/β-catenin信号通路,抑制视网膜色素上皮及视网膜微血管内皮细胞的增生和迁移,对维持血-视网膜屏障的稳定有重要作用,减少新生血管生成,对糖尿病视网膜病变等眼底疾病的发生发展有重要的影响。这可能为糖尿病视网膜病变等视网膜疾病的诊断和治疗提供新的策略。未来可能针对DKK-1研发更安全的特异性小分子药物或生物制剂,或与新的基因治疗技术相结合尝试新的治疗方法。

关键词: Dickkopf-1, 糖尿病视网膜病变, Wnt/β-catenin信号通路

Abstract: The Dickkopf (DKK) protein family plays a crucial role in biological development and cellular signal transduction. It mainly affects cell proliferation, apoptosis, and migration by regulating the Wnt/β-catenin signaling pathway, and plays a role in many diseases. DKK-1 inhibits the proliferation and migration of retinal pigment epithelium and retinal microvascular endothelial cells by suppressing the Wnt/β-catenin signaling pathway, which is important for maintaining the stability of the blood-retinal barrier, reducing neovascularization, and has a significant impact on the occurrence and development of fundus diseases such as diabetic retinopathy. This may provide new strategies for the diagnosis and treatment of retinal diseases such as diabetic retinopathy. In the future, it may be possible to develop safer specific small-molecule drugs or biological agents targeting DKK-1, or combine them with new gene therapy technologies to attempt new treatment methods for retinal diseases.

Key words: Dickkopf-1, Diabetic retinopathy, Wnt/β-catenin signaling pathway